TRW Automotive Holdings Corp. (TRW) Financials Nov 17,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
TRW Automotive Holdings Corp. (TRW) Financials Nov 17, 2014, 4:26 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TRW Automotive Holdings Corp.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 11.61B 14.38B 16.24B 16.44B 17.44B
Cost of Goods Sold (COGS) incl. D&A 10.57B 12.55B 14.4B 14.67B 15.52B
COGS excluding D&A 10.08B 12.08B 13.95B 14.26B 15.09B
Depreciation & Amortization Expense 495M 469M 447M 409M 430M
Depreciation 474M 447M 432M 397M 416M
Amortization of Intangibles 21M 22M 15M 12M 14M
Gross Income 1.04B 1.83B 1.85B 1.78B 1.92B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 650M 643M 627M 633M 628M
Research & Development 155M 132M 0 - 193M
Other SG&A 495M 511M 627M 633M 435M
Other Operating Expense 0 0 0 0 0
Unusual Expense 104M 68M 54M 87M 91M
EBIT after Unusual Expense (104M) (68M) (54M) (87M) (91M)
Non Operating Income/Expense 25M 48M 63M 22M 10M
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 15M 34M 39M 40M -
Interest Expense 186M 162M 118M 111M 132M
Gross Interest Expense 186M 162M 118M 111M 132M
Interest Capitalized 0 0 0 0 0
Pretax Income 140M 1.04B 1.15B 1.01B 1.08B
Income Tax 67M 166M (47M) (33M) 114M
Income Tax - Current Domestic (1M) 2M 1M 2M 0
Income Tax - Current Foreign 72M 108M 97M 169M 161M
Income Tax - Deferred Domestic (2M) 8M (164M) (107M) (46M)
Income Tax - Deferred Foreign (2M) 48M 19M (97M) (1M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 46M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 73M 875M 1.2B 1.04B 1.01B
Minority Interest Expense 18M 41M 38M 33M 37M
Net Income 55M 834M 1.16B 1.01B 970M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 55M 834M 1.16B 1.01B 970M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 55M 834M 1.16B 1.01B 970M
EPS (Basic) 0.51 6.96 9.37 8.24 8.25
Basic Shares Outstanding 107.8M 119.8M 123.5M 122.4M 117.6M
EPS (Diluted) 0.51 6.35 8.82 7.83 7.85
Diluted Shares Outstanding 108.7M 131.3M 133M 129.7M 124.6M
EBITDA 885M 1.66B 1.67B 1.55B 1.72B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading